Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4286363
Max Phase: Preclinical
Molecular Formula: C42H57N11O8
Molecular Weight: 843.99
Molecule Type: Small molecule
Associated Items:
ID: ALA4286363
Max Phase: Preclinical
Molecular Formula: C42H57N11O8
Molecular Weight: 843.99
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/N=C(/NC)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C42H57N11O8/c1-45-42(46-2)47-20-12-19-30(38(58)51-31(37(44)57)21-27-13-6-3-7-14-27)50-40(60)33(23-29-17-10-5-11-18-29)52-41(61)34(26-54)53-39(59)32(22-28-15-8-4-9-16-28)49-36(56)25-48-35(55)24-43/h3-11,13-18,30-34,54H,12,19-26,43H2,1-2H3,(H2,44,57)(H,48,55)(H,49,56)(H,50,60)(H,51,58)(H,52,61)(H,53,59)(H2,45,46,47)/t30-,31-,32-,33-,34-/m0/s1
Standard InChI Key: BUTLEQIALMEFRP-LJADHVKFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 843.99 | Molecular Weight (Monoisotopic): 843.4392 | AlogP: -2.73 | #Rotatable Bonds: 24 |
Polar Surface Area: 300.36 | Molecular Species: BASE | HBA: 10 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.68 | CX Basic pKa: 11.50 | CX LogP: -2.90 | CX LogD: -5.21 |
Aromatic Rings: 3 | Heavy Atoms: 61 | QED Weighted: 0.03 | Np Likeness Score: -0.18 |
1. Alim K, Lefranc B, Sopkova-de Oliveira Santos J, Dubessy C, Picot M, Boutin JA, Vaudry H, Chartrel N, Vaudry D, Chuquet J, Leprince J.. (2018) Design, Synthesis, Molecular Dynamics Simulation, and Functional Evaluation of a Novel Series of 26RFa Peptide Analogues Containing a Mono- or Polyalkyl Guanidino Arginine Derivative., 61 (22): [PMID:30358997] [10.1021/acs.jmedchem.8b01332] |
Source(1):